ArticlePloS one2026
Estimating cumulative incidence from partially missing time series of respiratory viral infections.
Article in PloS one, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundSeasonal respiratory viruses, including respiratory syncytial virus (RSV) and human metapneumovirus (hMPV), are major contributors to global respiratory infection burden. Estimating viral incidence using real-world data (RWD) is challenging as misalignment of data collection with seasonal circulation can lead to underestimated incidence and hinder inter-study comparisons.
methodsWe developed a regression-based approach to retrospectively correct partial-season time series with contiguous missing weeks at the start or end of a season. Weekly RSV clinical incidence (per 100,000) was extracted from U.S. RWD sources (Optum® CDM and PharMetrics Plus, adults ≥65 years; Kaiser Permanente Northwest [KPNW], all ages) for seasons 2018-19 to 2023-24 and aligned to RSV‑Net hospitalization surveillance. Weekly early- and late-season missingness scenarios were created (approximately 10%, 15%, 20%, and 25% of weeks removed). Models were fit within each season using harmonic terms and the surveillance-aligned covariate. Uncertainty was quantified using moving block bootstrap 95% prediction intervals. Weekly accuracy was evaluated using RMSE and normalized RMSE, and seasonal burden reconstruction accuracy using cumulative percent error and signed difference. For hMPV, we evaluated an illustrative extension using Optum® CDM (adults ≥65 years; 2022-23 and 2023-24) and NREVSS test positivity; because positivity is bounded and depends on testing volume, we used a denominator-aware binomial/logit model (positives out of tests).
resultsFor RSV, weekly prediction error increased with missingness level, while reconstructed seasonal burden generally remained close to observed totals in applicable scenarios. Early-season gaps were associated with larger cumulative errors than late-season gaps in Optum® CDM and PharMetrics Plus, whereas late-season median percent errors were closer to zero across missingness levels. Applicability was reduced primarily for higher early-season missingness in KPNW due to peak overlap (e.g., early 25% scenarios not applicable). For hMPV test positivity (illustrative; two seasons), weekly prediction RMSE was on the order of ~1-2 percentage points across missingness scenarios.
conclusionAcross multiple RSV seasons and data sources, reconstructed seasonal burden generally agreed with observed totals when missingness was confined to contiguous early- or late-season weeks and did not overlap peak activity. This approach provides a transparent method to improve the utility and comparability of partial-season respiratory virus time series. However, applicability is reduced when peak weeks are missing, and hMPV findings are illustrative given limited seasons and the use of test positivity.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.